EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Spatial distribution and subtype‐specific expression patterns of Nectin‐4 in muscle‐invasive bladder cancer

Csilla Olah iD, Lara Sichward, Boris Hadaschik, Christopher Darr, Viktor Grünwald, Ulrich Krafft, Barbara T Grünwald, Osama Mahmoud, Mulham Al-Nader, Peter Nyirady, Henning Reis, Tibor Szarvas

BJU International · 2025-08 · 136 (2) · 297-305

DOI: 10.1111/bju.16643 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BJU International, online erschienen am 13.01.2025. Verfasst von Csilla Olah und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, University of Duisburg-Essen, Essen, Germany. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Cell Adhesion Molecules, Carcinoma, Transitional Cell. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry for Innovation and Technology from the source of the National Research Development and Innovation Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To investigate the expression patterns of Nectin‐4, the target molecule of the antibody‐drug conjugate enfortumab vedotin (EV), in relation to histological and molecular subtypes of urothelial bladder cancer (UBC). Patients and Methods We assessed the protein expression patterns of Nectin‐4 in a spatially organised tissue microarray containing 1386 tissue cores from 314 consecutive patients with UBC who underwent radical cystectomy (2005–2018). Results were correlated with clinicopathological and follow‐up data, as well as with different spatial locations (tumour central vs tumour‐normal interface and primary tumour vs lymph node [LN] metastases). Additionally, we correlated Nectin‐4 expression levels with histological and molecular subtypes. Finally, we assessed the value of Nectin‐4 expression for predicting the efficacy of platinum therapy in the peri‐operative setting.

Results

Nectin‐4 expression was observed in 63% of primary tumours and 87% of LN metastases, with significantly higher levels in LNs. Of the histological subtypes, the micropapillary (58%) and pure urothelial histologies (30%) were associated with the highest Nectin‐4 positivity, while the sarcomatoid (17%), squamous (15%) and small/cell‐neuroendocrine (0%) subtypes exhibited the lowest. Nectin‐4 immunopositivity rates were significantly higher in luminal (urothelial‐like [42%] and genomically unstable [34%] Lund subtypes) compared to the basal (5%) or mesenchymal (0%) molecular subtypes. Higher Nectin‐4 expression levels were associated with lower tumour stage but showed no association with overall survival. Finally, patients with low Nectin‐4 expression tended to derive more benefit from platinum‐based chemotherapy in both adjuvant and neoadjuvant settings ( P < 0.001, P = 0.067).

Conclusion

Our results revealed a low spatial heterogeneity of Nectin‐4 expression within the primary tumour. In contrast, differential Nectin‐4 expression was found in the context of histological and molecular subtypes. Nectin‐4‐expressing tumours may show varying sensitivity to both EV and platinum‐based chemotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsCell Adhesion MoleculesCarcinoma, Transitional CellHumansMaleFemaleAgedMiddle AgedNeoplasm InvasivenessCystectomyLymphatic MetastasisAged, 80 and overBiomarkers, TumorNectins

Stichwörter der Autor:innen

bladder cancercisplatinenfortumab vedotinimmune checkpoint inhibitorimmunohistochemistrymolecular subtypenectin‐4

Substanzen

NECTIN4 protein, humanCell Adhesion MoleculesBiomarkers, TumorNectins

Autor:innen und Institutionen

  • Department of Urology, University of Duisburg-Essen, Essen, Germany.
  • Institute of Pathology, University Medicine Essen, University of Duisburg-Essen, Essen, Germany.
  • Department of Medical Oncology, University of Duisburg-Essen, Essen, Germany.
  • Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Department of Urology, Qena Faculty of Medicine, South Valley University, Qena, Egypt.
  • Department of Urology, Semmelweis University, Budapest, Hungary.

ORCID-Profile: Csilla Olah

Förderung

  • Ministry for Innovation and Technology from the source of the National Research Development and Innovation Fund

Zitieren

APA

Olah, C., Sichward, L., Hadaschik, B., Darr, C., Grünwald, V., Krafft, U., Grünwald, B. T., Mahmoud, O., Al-Nader, M., Nyirady, P., Reis, H., & Szarvas, T. (2025). Spatial distribution and subtype‐specific expression patterns of Nectin‐4 in muscle‐invasive bladder cancer. BJU International, 136(2), 297-305. https://doi.org/10.1111/bju.16643

Vancouver

Olah C, Sichward L, Hadaschik B, Darr C, Grünwald V, Krafft U, et al. Spatial distribution and subtype‐specific expression patterns of Nectin‐4 in muscle‐invasive bladder cancer. BJU International. 2025;136(2):297-305. doi:10.1111/bju.16643

BibTeX
@article{Olah2025,
  author = {Olah, Csilla and Sichward, Lara and Hadaschik, Boris and Darr, Christopher and Grünwald, Viktor and Krafft, Ulrich and Grünwald, Barbara T and Mahmoud, Osama and Al-Nader, Mulham and Nyirady, Peter and Reis, Henning and Szarvas, Tibor},
  title = {Spatial distribution and subtype‐specific expression patterns of Nectin‐4 in muscle‐invasive bladder cancer},
  journal = {BJU International},
  year = {2025},
  volume = {136},
  number = {2},
  pages = {297--305},
  doi = {10.1111/bju.16643}
}
Kostenlos starten →